Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Nervous System Diseases (313)
- Life Sciences (3)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
- Social and Behavioral Sciences (2)
- Animal Experimentation and Research (1)
-
- Applied Behavior Analysis (1)
- Behavioral Neurobiology (1)
- Biological Psychology (1)
- Biology (1)
- Cell Biology (1)
- Cell and Developmental Biology (1)
- Gender and Sexuality (1)
- Genetics (1)
- Genetics and Genomics (1)
- Medical Sciences (1)
- Neuroscience and Neurobiology (1)
- Neurosciences (1)
- Occupational Therapy (1)
- Psychology (1)
- Rehabilitation and Therapy (1)
- Research Methods in Life Sciences (1)
- Sociology (1)
- Systems Neuroscience (1)
- Institution
- Publication Year
- Publication
- Publication Type
Articles 61 - 90 of 315
Full-Text Articles in Diseases
New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin
New Ionis Data Show Positive Trends In Clinical Measures Of Huntington's Disease Drug Trial Volunteers, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin
Nora Guthrie: We’Re All ‘Hoping Machines’ In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin
Roche Gears Up For Pivotal Phase 3 Huntington’S Disease Gene-Slicing Clinical Trial, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin
In Chronicling The Quest To Cure Huntington’S Disease, A Whirlwind Of Emotions, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin
The Best News For The Huntington's Disease Community Since The Discovery Of The Gene: Ionis Trial Data Revealed, Roche Confirms Jump To Phase 3, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Overflow Audience At 13th Annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin
Overflow Audience At 13th Annual Huntington's Disease Therapeutics Conference, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Chdi's 13th Conference Promises Some Good News For The Huntington's Disease Community, Kenneth P. Serbin
Chdi's 13th Conference Promises Some Good News For The Huntington's Disease Community, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Faith In Each Other: Sticking Together Through The Challenges Of Huntington's Disease, Kenneth P. Serbin
Faith In Each Other: Sticking Together Through The Challenges Of Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Possible Breakdown Of Dopamine Receptor Synergism In A Mouse Model Of Huntington's Disease, Samantha F. Kennedy
Possible Breakdown Of Dopamine Receptor Synergism In A Mouse Model Of Huntington's Disease, Samantha F. Kennedy
LSU New Orleans Theses and Dissertations
The model of basal ganglia function proposed by Albin, Young and Penney (1989) describes two anatomically independent motor pathways, the direct and indirect. However, under normal conditions striatal dopamine (DA) is required for the expression of motor behavior, and DAergic control of the two pathways (via D1 and D2 receptors, respectively) is dependent on co-activation. We tested for a possible breakdown of D1/D2 synergism using transgenic R6/1 mice bearing the human huntingtin allele (Htt). Motor stereotypy, observed prior to the onset of HD-related symptoms, was rated on a 5-point scale following activation of: A) D1 receptors alone, B) D2 receptors …
Ionis Scientists Provide Initial Assessment Of Successful Phase 1/2a Huntington's Disease Trial And Discuss Next Steps, Kenneth P. Serbin
Ionis Scientists Provide Initial Assessment Of Successful Phase 1/2a Huntington's Disease Trial And Discuss Next Steps, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Ionis Drug Successfully Reduces Toxic Huntington’S Disease Protein, Paving Way For Phase 2 Trial Of Effect On Patients, Kenneth P. Serbin
Ionis Drug Successfully Reduces Toxic Huntington’S Disease Protein, Paving Way For Phase 2 Trial Of Effect On Patients, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
A Time For Hope: Hdsa’S 50th Anniversary, A Record-Setting Gala, And The Impending Release Of Highly Anticipated Clinical Trial Results, Kenneth P. Serbin
A Time For Hope: Hdsa’S 50th Anniversary, A Record-Setting Gala, And The Impending Release Of Highly Anticipated Clinical Trial Results, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Advocacy In The Workplace: Raising Awareness About Huntington's Disease And Brain Health, Kenneth P. Serbin
Advocacy In The Workplace: Raising Awareness About Huntington's Disease And Brain Health, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Ionis Huntington’S Disease Drug A Step Closer To A Critical Phase 2 Study, Kenneth P. Serbin
Ionis Huntington’S Disease Drug A Step Closer To A Critical Phase 2 Study, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Join The Facebook Live Event (Soon!) On Pope Francis's Historic Audience With Huntington's Disease Families, Kenneth P. Serbin
Join The Facebook Live Event (Soon!) On Pope Francis's Historic Audience With Huntington's Disease Families, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Francis Made A Day Of ‘Superlatives’ For The Huntington's Disease Community, Says Event Co-Organizer, Kenneth P. Serbin
Francis Made A Day Of ‘Superlatives’ For The Huntington's Disease Community, Says Event Co-Organizer, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Pope Francis Declares: Huntington’S Disease Should Be 'Hidden No More', Kenneth P. Serbin
Pope Francis Declares: Huntington’S Disease Should Be 'Hidden No More', Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Fear Not, Huntington’S Disease Families – Pope Francis Has Our Backs, Kenneth P. Serbin
Fear Not, Huntington’S Disease Families – Pope Francis Has Our Backs, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Preparing For The Meeting With Pope Francis, A Heartening Milestone In The Huntington's Disease Movement, Kenneth P. Serbin
Preparing For The Meeting With Pope Francis, A Heartening Milestone In The Huntington's Disease Movement, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Pope Francis I To Meet With Victims Of Huntington’S Disease, A First For A World Leader, Kenneth P. Serbin
Pope Francis I To Meet With Victims Of Huntington’S Disease, A First For A World Leader, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Staying When The Chargers Leave: A Leading Huntington's Disease Advocate Sets A Gutsy, Loving Example, Kenneth P. Serbin
Staying When The Chargers Leave: A Leading Huntington's Disease Advocate Sets A Gutsy, Loving Example, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Banning College Football: An Urgent Objective For Brain Health Advocates, Kenneth P. Serbin
Banning College Football: An Urgent Objective For Brain Health Advocates, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Passing On The Huntington’S Disease Advocacy Baton To The Next Generation, Kenneth P. Serbin
Passing On The Huntington’S Disease Advocacy Baton To The Next Generation, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
This Thanksgiving, Let’S Show Gratitude For Disease Researchers And Drug Hunters, Kenneth P. Serbin
This Thanksgiving, Let’S Show Gratitude For Disease Researchers And Drug Hunters, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
‘Crying A Few Million Tears’ For The Fallen Victims Of Huntington's Disease, Kenneth P. Serbin
‘Crying A Few Million Tears’ For The Fallen Victims Of Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Ionis Phase I Huntington’S Disease Trial At Halfway Mark: 'No Surprises So Far' Means Good News, Kenneth P. Serbin
Ionis Phase I Huntington’S Disease Trial At Halfway Mark: 'No Surprises So Far' Means Good News, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Dreams For A Better Future: An Opportunity We Huntington's Disease People And Our Families Are Denied, Kenneth P. Serbin
Dreams For A Better Future: An Opportunity We Huntington's Disease People And Our Families Are Denied, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
Upbeat Huntington’S Disease Film, Featuring Undaunted Family, Aims For 10 Million Views, Kenneth P. Serbin
Upbeat Huntington’S Disease Film, Featuring Undaunted Family, Aims For 10 Million Views, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
A Family United Against Huntington’S Disease, Kenneth P. Serbin
A Family United Against Huntington’S Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.
From Sheepish To Self-Assured In The Fight Against Huntington's Disease, Kenneth P. Serbin
From Sheepish To Self-Assured In The Fight Against Huntington's Disease, Kenneth P. Serbin
At Risk for Huntington's Disease
No abstract provided.